American Chemical Society 230th National Meeting. Pain, anxiety and depression.
Ognjenovic
Marica
M
Thomson Scientific, Middlesex House, London, UK. Marica.Ognjenovic@thomson.com
Perry
Letitia
L
D000700:Analgesics / Q000138:chemical synthesis* / Q000494:pharmacology; D000818:Animals; D014151:Anti-Anxiety Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D000928:Antidepressive Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D058785:GABA-A Receptor Agonists; D006801:Humans; D015221:Potassium Channels / Q000187:drug effects; D018019:Receptors, Corticotropin-Releasing Hormone / Q000037:antagonists & inhibitors; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors; D017465:Receptors, Opioid, delta / Q000819:agonists; D017367:Selective Serotonin Reuptake Inhibitors / Q000138:chemical synthesis / Q000494:pharmacology; D000099052:CRF Receptor, Type 1
D000700:Analgesics; D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D058785:GABA-A Receptor Agonists; D015221:Potassium Channels; D018019:Receptors, Corticotropin-Releasing Hormone; D016194:Receptors, N-Methyl-D-Aspartate; D017465:Receptors, Opioid, delta; D017367:Selective Serotonin Reuptake Inhibitors; D000099052:CRF Receptor, Type 1